BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29548050)

  • 1. Radiomics, Metabolic, and Molecular MRI for Brain Tumors.
    Kickingereder P; Andronesi OC
    Semin Neurol; 2018 Feb; 38(1):32-40. PubMed ID: 29548050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics in Brain Tumors: An Emerging Technique for Characterization of Tumor Environment.
    Kotrotsou A; Zinn PO; Colen RR
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):719-729. PubMed ID: 27742112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics derived from amino-acid PET and conventional MRI in patients with high-grade gliomas.
    Lohmann P; Kocher M; Steger J; Galldiks N
    Q J Nucl Med Mol Imaging; 2018 Sep; 62(3):272-280. PubMed ID: 29869488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma.
    Grossmann P; Gutman DA; Dunn WD; Holder CA; Aerts HJ
    BMC Cancer; 2016 Aug; 16():611. PubMed ID: 27502180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance metabolic imaging of glioma.
    Metellus P; Figarella-Branger D
    Sci Transl Med; 2012 Jan; 4(116):116ps1. PubMed ID: 22238331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in neuro-imaging of brain tumors.
    Castellano A; Falini A
    Curr Opin Oncol; 2016 Nov; 28(6):484-493. PubMed ID: 27649026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive metabolic imaging of brain tumours in the era of precision medicine.
    Kim MM; Parolia A; Dunphy MP; Venneti S
    Nat Rev Clin Oncol; 2016 Dec; 13(12):725-739. PubMed ID: 27430748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.
    Sauwen N; Acou M; Van Cauter S; Sima DM; Veraart J; Maes F; Himmelreich U; Achten E; Van Huffel S
    Neuroimage Clin; 2016; 12():753-764. PubMed ID: 27812502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics and radiogenomics in gliomas: a contemporary update.
    Singh G; Manjila S; Sakla N; True A; Wardeh AH; Beig N; Vaysberg A; Matthews J; Prasanna P; Spektor V
    Br J Cancer; 2021 Aug; 125(5):641-657. PubMed ID: 33958734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients.
    Jafari-Khouzani K; Loebel F; Bogner W; Rapalino O; Gonzalez GR; Gerstner E; Chi AS; Batchelor TT; Rosen BR; Unkelbach J; Shih HA; Cahill DP; Andronesi OC
    Neuro Oncol; 2016 Nov; 18(11):1569-1578. PubMed ID: 27382115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomics of brain tumor imaging.
    Pope WB
    Neuroimaging Clin N Am; 2015 Feb; 25(1):105-19. PubMed ID: 25476516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From K-space to Nucleotide: Insights Into the Radiogenomics of Brain Tumors.
    Elshafeey N; Hassan I; Zinn PO; Colen RR
    Top Magn Reson Imaging; 2017 Feb; 26(1):33-41. PubMed ID: 28079715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuro-Oncology and Radiogenomics: Time to Integrate?
    Lasocki A; Rosenthal MA; Roberts-Thomson SJ; Neal A; Drummond KJ
    AJNR Am J Neuroradiol; 2020 Nov; 41(11):1982-1988. PubMed ID: 32912874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light.
    Maggio I; Franceschi E; Gatto L; Tosoni A; Di Nunno V; Tonon C; Brandes AA
    Expert Rev Anticancer Ther; 2021 Nov; 21(11):1265-1272. PubMed ID: 34433354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic Susceptibility Contrast MR Imaging in Glioma: Review of Current Clinical Practice.
    Boxerman JL; Shiroishi MS; Ellingson BM; Pope WB
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):649-670. PubMed ID: 27742108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics in gliomas: A promising assistance 
for glioma clinical research.
    Leng Y; Wang X; Liao W; Cao Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):354-359. PubMed ID: 29774870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Applications of Artificial Intelligence in Neuro-Oncology.
    Rudie JD; Rauschecker AM; Bryan RN; Davatzikos C; Mohan S
    Radiology; 2019 Mar; 290(3):607-618. PubMed ID: 30667332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics in neuro-oncology: Basics, workflow, and applications.
    Lohmann P; Galldiks N; Kocher M; Heinzel A; Filss CP; Stegmayr C; Mottaghy FM; Fink GR; Jon Shah N; Langen KJ
    Methods; 2021 Apr; 188():112-121. PubMed ID: 32522530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate.
    Andronesi OC; Loebel F; Bogner W; Marjańska M; Vander Heiden MG; Iafrate AJ; Dietrich J; Batchelor TT; Gerstner ER; Kaelin WG; Chi AS; Rosen BR; Cahill DP
    Clin Cancer Res; 2016 Apr; 22(7):1632-41. PubMed ID: 26534967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Advanced Brain Tumor Imaging in the Care of Patients with Central Nervous System Malignancies.
    Ly KI; Gerstner ER
    Curr Treat Options Oncol; 2018 Jun; 19(8):40. PubMed ID: 29931476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.